Literature DB >> 34905100

Immunomodulatory Effect of Bifidobacterium, Lactobacillus, and Streptococcus Strains of Paraprobiotics in Lipopolysaccharide-Stimulated Inflammatory Responses in RAW-264.7 Macrophages.

Monique Michels1,2,3, Gabriel Fernandes Alves Jesus4, Ana Paula Lorenzen Voytena4, Marina Rossetto4, Fernanda Ramlov4, Emily Córneo5, Paulo Feuser5, Daniel Gelain6, Felipe Dal-Pizzol5.   

Abstract

The discovery of the potential of paraprobiotics to exert different immunological benefits suggests that further studies should be carried out to determine their potential and mechanisms of action in modulating the immune system. The objective of this study was to investigate the immune response of several microbial-associated molecular patterns (MAMPS) used at different doses in macrophage cell lines RAW-264.7 stimulated with lipopolysaccharide (LPS). Two experiments were conducted. The first was performed to determine a dose response curve for each paraprobiotic (Bifidobacterium lactis, Lactobacillus casei, Lactobacillus gasseri, Lactobacillus paracasei, and Streptococcus thermophilus). Further experiments were carried using only two doses (0.01 g/ml and 0.1 g/ml). RAW-264.7 cells were cultivated in Dubelcco's Modified Eagle's medium supplemented with fetal bovine serum and penicillin/streptomycin. Cells were incubated with LPS (1 μg/ml) and six concentrations of MAMPs were added. RAW-264.7 viability, myeloperoxidase activity, nitrite/nitrate concentration, reactive oxygen species production, oxidative damage, and inflammatory parameters were measured. In the LPS group, there was a significant reduction in cell viability. Myeloperoxidase and nitrite/nitrate concentrations demonstrated a better effect at 0.01 and 0.1 g/ml doses. There was a significant reduction in interleukin-6 (IL-6) levels at 0.1 g/ml dose in all paraprobiotics. IL-10 levels decreased in the LPS group and increased at 0.1 g/ml dose in all paraprobiotics. The dichlorofluorescin diacetate results were reinforced by the observed in oxidative damage. Paraprobiotics are likely to contribute to the improvement of intestinal homeostasis, immunomodulation, and host metabolism.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34905100     DOI: 10.1007/s00284-021-02708-1

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  54 in total

1.  Safety assessment of Bacillus licheniformis Me1 isolated from milk for probiotic application.

Authors:  Vadakedath Nithya; Serva P Muthukumar; Prakash M Halami
Journal:  Int J Toxicol       Date:  2012-06       Impact factor: 2.032

2.  Oral supplementation with Lactobacillus delbrueckii subsp. bulgaricus 8481 enhances systemic immunity in elderly subjects.

Authors:  Marco Antonio Moro-García; Rebeca Alonso-Arias; Maria Baltadjieva; Carlos Fernández Benítez; Manuel Amadeo Fernández Barrial; Enrique Díaz Ruisánchez; Ricardo Alonso Santos; Magdalena Alvarez Sánchez; Juan Saavedra Miján; Carlos López-Larrea
Journal:  Age (Dordr)       Date:  2012-05-30

3.  Controversy over mammographic screening.

Authors:  L Fallowfield
Journal:  BMJ       Date:  1988-11-12

4.  Lactococcus lactis expressing food-grade β-galactosidase alleviates lactose intolerance symptoms in post-weaning Balb/c mice.

Authors:  Jingjie Li; Wen Zhang; Chuan Wang; Qian Yu; Ruirui Dai; Xiaofang Pei
Journal:  Appl Microbiol Biotechnol       Date:  2012-03-08       Impact factor: 4.813

Review 5.  Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.

Authors:  Anna Iacono; Giuseppina Mattace Raso; Roberto Berni Canani; Antonio Calignano; Rosaria Meli
Journal:  J Nutr Biochem       Date:  2011-02-02       Impact factor: 6.048

Review 6.  Probiotic therapy: immunomodulating approach toward urinary tract infection.

Authors:  Sarika Amdekar; Vinod Singh; Desh Deepak Singh
Journal:  Curr Microbiol       Date:  2011-09-07       Impact factor: 2.188

7.  Evaluation of characteristics of Pediococcus spp. to be used as a vaginal probiotic.

Authors:  S Borges; J Barbosa; J Silva; P Teixeira
Journal:  J Appl Microbiol       Date:  2013-05-16       Impact factor: 3.772

8.  Efficacy of Bacillus clausii strain UBBC-07 in the treatment of patients suffering from acute diarrhoea.

Authors:  M Ratna Sudha; S Bhonagiri; M Asin Kumar
Journal:  Benef Microbes       Date:  2013-06-01       Impact factor: 4.205

9.  Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome.

Authors:  Philippe Ducrotté; Prabha Sawant; Venkataraman Jayanthi
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

10.  Photoprotective effects of Bifidobacterium breve supplementation against skin damage induced by ultraviolet irradiation in hairless mice.

Authors:  Saho Sugimoto; Yuki Ishii; Naoki Izawa; Norie Masuoka; Mitsuyoshi Kano; Toshiro Sone; Katsuyoshi Chiba; Kouji Miyazaki; Fumiyasu Ishikawa
Journal:  Photodermatol Photoimmunol Photomed       Date:  2012-12       Impact factor: 3.135

View more
  1 in total

1.  Paraprobiotics in Non-Surgical Periodontal Therapy: Clinical and Microbiological Aspects in a 6-Month Follow-Up Domiciliary Protocol for Oral Hygiene.

Authors:  Andrea Butera; Simone Gallo; Maurizio Pascadopoli; Carolina Maiorani; Antonella Milone; Mario Alovisi; Andrea Scribante
Journal:  Microorganisms       Date:  2022-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.